Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

IHS Markit (INFO) Hits A New 52-Week High: What's Aiding It?

Published 01/14/2020, 06:33 AM
Updated 07/09/2023, 06:31 AM

Shares of IHS Markit Inc. (NYSE:INFO) scaled a new 52-week high of $79.96 in the trading session on Jan 13, before closing a tad lower at $79.93.

The company’s shares have charted a solid trajectory in recent times, appreciating 61% over the past year, ahead of the 44% growth of the industry it belongs to and 25.6% rally of the Zacks S&P 500 composite.

Notably, IHS Markit has witnessed a 21.2% rise in share price since it posted third-quarter fiscal 2019 results.

Let’s find out what’s supporting the uptick.

Consecutive Earnings Beat

IHS Markit reported better-than-expected earnings performance in the first three quarters of fiscal 2019. Notably, the company’s operational efficiency and financial discipline, which contribute to margin expansion, continued to boost its bottom line. Its adjusted EBITDA expanded 16% and adjusted EBITDA margin improved 130 basis points in the first nine months of fiscal 2019, on a year-over-year basis.

Solid Recurring Revenue Generation

IHS Markit’s business model ensures solid recurring revenue generation capacity. Its products and services are offered primarily through recurring fixed and variable fee agreements, which allows the company to deliver stable revenues and cash flows. Its recurring revenues increased 12.1% in the third quarter and 12.6% in the first nine months of fiscal 2019, on a year-over-year basis.

Prudent Business Moves With Healthy Cash Flow

IHS Markit’s business requires low capital requirement, which in turn, boosts its cash generation capacity and allows it to pursue acquisition opportunities. Strategic acquisitions over time have helped the company to expand offerings and strengthen international footprint. It is also benefiting from highly-diversified global customer base and strong brand recognition.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company’s free cash flow increased 8% year over year in the first nine months of fiscal 2019. Cash flow from operations improved 10% year over year during the same time period.

Zacks Rank & Stocks to Consider

Currently, IHS Markit carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Zacks Business Services sector are ICF International (NASDAQ:ICFI) , Accenture (NYSE:ACN) and Booz Allen Hamilton (NYSE:BAH) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term expected EPS (three to five years) growth rate for ICF International, Accenture and Booz Allen Hamilton is 10%, 10.3% and 13%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



IHS Markit Ltd. (INFO): Free Stock Analysis Report

Accenture PLC (ACN): Free Stock Analysis Report

Booz Allen Hamilton Holding Corporation (BAH): Free Stock Analysis Report

ICF International, Inc. (ICFI): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.